| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcranial Magnetic Stimulation | 142 | 2023 | 413 | 30.160 |
Why?
|
| Prefrontal Cortex | 86 | 2023 | 640 | 14.720 |
Why?
|
| Depressive Disorder, Major | 41 | 2022 | 439 | 7.520 |
Why?
|
| Brain | 66 | 2022 | 2176 | 6.510 |
Why?
|
| Magnetic Resonance Imaging | 78 | 2022 | 2223 | 6.410 |
Why?
|
| Electric Stimulation Therapy | 27 | 2022 | 147 | 6.360 |
Why?
|
| Motor Cortex | 24 | 2022 | 158 | 6.170 |
Why?
|
| Transcranial Direct Current Stimulation | 21 | 2022 | 111 | 5.800 |
Why?
|
| Depressive Disorder | 29 | 2020 | 621 | 4.480 |
Why?
|
| Vagus Nerve Stimulation | 12 | 2022 | 61 | 3.960 |
Why?
|
| Vagus Nerve | 24 | 2022 | 90 | 3.810 |
Why?
|
| Pain | 18 | 2020 | 472 | 3.630 |
Why?
|
| Cerebral Cortex | 19 | 2022 | 415 | 3.510 |
Why?
|
| Tobacco Use Disorder | 14 | 2021 | 432 | 3.430 |
Why?
|
| Depression | 26 | 2023 | 943 | 3.260 |
Why?
|
| Deep Brain Stimulation | 14 | 2023 | 71 | 3.190 |
Why?
|
| Mental Disorders | 15 | 2023 | 659 | 3.190 |
Why?
|
| Brain Mapping | 37 | 2022 | 532 | 3.130 |
Why?
|
| Electroconvulsive Therapy | 18 | 2021 | 402 | 3.080 |
Why?
|
| Humans | 277 | 2023 | 68618 | 3.060 |
Why?
|
| Adult | 149 | 2022 | 21403 | 2.820 |
Why?
|
| Periodicals as Topic | 10 | 2012 | 158 | 2.600 |
Why?
|
| Electric Stimulation | 17 | 2022 | 218 | 2.490 |
Why?
|
| Craving | 7 | 2017 | 200 | 2.470 |
Why?
|
| Evoked Potentials, Motor | 13 | 2021 | 63 | 2.440 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 10 | 2021 | 29 | 2.380 |
Why?
|
| Pain Management | 9 | 2015 | 186 | 2.350 |
Why?
|
| Bipolar Disorder | 14 | 2016 | 307 | 2.330 |
Why?
|
| Male | 157 | 2021 | 37321 | 2.310 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 7 | 2022 | 40 | 2.260 |
Why?
|
| Female | 148 | 2022 | 38074 | 2.200 |
Why?
|
| Pain Threshold | 8 | 2020 | 55 | 2.200 |
Why?
|
| Middle Aged | 110 | 2021 | 21147 | 2.110 |
Why?
|
| Treatment Outcome | 70 | 2023 | 7029 | 2.110 |
Why?
|
| Functional Laterality | 23 | 2014 | 240 | 2.090 |
Why?
|
| Psychiatry | 5 | 2019 | 112 | 2.080 |
Why?
|
| Smoking Cessation | 9 | 2020 | 1034 | 2.060 |
Why?
|
| Analgesia | 7 | 2014 | 58 | 2.050 |
Why?
|
| Pain, Postoperative | 6 | 2017 | 214 | 1.900 |
Why?
|
| Oxygen | 19 | 2016 | 386 | 1.810 |
Why?
|
| Double-Blind Method | 32 | 2021 | 1738 | 1.750 |
Why?
|
| Gyrus Cinguli | 11 | 2018 | 113 | 1.740 |
Why?
|
| Pilot Projects | 28 | 2020 | 1342 | 1.720 |
Why?
|
| Pain Measurement | 19 | 2017 | 328 | 1.680 |
Why?
|
| Antidepressive Agents | 17 | 2022 | 216 | 1.680 |
Why?
|
| Young Adult | 42 | 2021 | 5717 | 1.670 |
Why?
|
| Pain Perception | 4 | 2014 | 22 | 1.670 |
Why?
|
| Deception | 6 | 2009 | 18 | 1.670 |
Why?
|
| Cues | 15 | 2018 | 654 | 1.640 |
Why?
|
| Electroencephalography | 12 | 2020 | 418 | 1.610 |
Why?
|
| Triazines | 5 | 2011 | 48 | 1.610 |
Why?
|
| Smoking | 9 | 2020 | 1452 | 1.520 |
Why?
|
| Brain Diseases | 6 | 2015 | 78 | 1.510 |
Why?
|
| Neurofeedback | 5 | 2016 | 34 | 1.510 |
Why?
|
| Schizophrenia | 10 | 2020 | 206 | 1.430 |
Why?
|
| Nerve Net | 9 | 2020 | 181 | 1.390 |
Why?
|
| Cross-Over Studies | 16 | 2020 | 260 | 1.370 |
Why?
|
| Memory | 7 | 2018 | 214 | 1.360 |
Why?
|
| Chronic Pain | 3 | 2018 | 110 | 1.350 |
Why?
|
| Parietal Lobe | 7 | 2017 | 59 | 1.340 |
Why?
|
| Obsessive-Compulsive Disorder | 5 | 2019 | 88 | 1.270 |
Why?
|
| Single-Blind Method | 13 | 2018 | 249 | 1.260 |
Why?
|
| Sensorimotor Cortex | 3 | 2019 | 18 | 1.250 |
Why?
|
| Stress Disorders, Post-Traumatic | 14 | 2022 | 1506 | 1.230 |
Why?
|
| Image Processing, Computer-Assisted | 20 | 2018 | 689 | 1.170 |
Why?
|
| Neural Inhibition | 5 | 2017 | 80 | 1.150 |
Why?
|
| Analgesics, Opioid | 5 | 2018 | 498 | 1.140 |
Why?
|
| Limbic System | 3 | 2013 | 106 | 1.080 |
Why?
|
| Burning Mouth Syndrome | 2 | 2015 | 5 | 1.040 |
Why?
|
| Valproic Acid | 3 | 2011 | 93 | 1.030 |
Why?
|
| Parkinson Disease | 4 | 2017 | 272 | 1.020 |
Why?
|
| Psychiatric Status Rating Scales | 24 | 2018 | 782 | 1.020 |
Why?
|
| Anticonvulsants | 4 | 2011 | 223 | 1.000 |
Why?
|
| Seizures | 10 | 2022 | 279 | 0.990 |
Why?
|
| Memory, Short-Term | 5 | 2022 | 79 | 0.950 |
Why?
|
| Precision Medicine | 3 | 2023 | 111 | 0.940 |
Why?
|
| Time Factors | 26 | 2020 | 4655 | 0.930 |
Why?
|
| Behavior, Addictive | 4 | 2013 | 317 | 0.910 |
Why?
|
| Adolescent | 28 | 2017 | 8912 | 0.850 |
Why?
|
| Cocaine-Related Disorders | 3 | 2018 | 504 | 0.850 |
Why?
|
| Functional Neuroimaging | 8 | 2021 | 82 | 0.840 |
Why?
|
| Corpus Striatum | 4 | 2018 | 279 | 0.830 |
Why?
|
| Movement | 9 | 2013 | 179 | 0.820 |
Why?
|
| Nervous System Diseases | 3 | 2008 | 142 | 0.810 |
Why?
|
| Frontal Lobe | 7 | 2017 | 156 | 0.800 |
Why?
|
| Aged | 36 | 2022 | 14862 | 0.800 |
Why?
|
| Emotions | 6 | 2014 | 244 | 0.790 |
Why?
|
| Lie Detection | 4 | 2009 | 6 | 0.780 |
Why?
|
| Magnetics | 7 | 2010 | 52 | 0.770 |
Why?
|
| Receptors, AMPA | 1 | 2021 | 99 | 0.770 |
Why?
|
| Hyperalgesia | 2 | 2011 | 18 | 0.770 |
Why?
|
| N-Methylaspartate | 1 | 2021 | 59 | 0.750 |
Why?
|
| Anterior Thalamic Nuclei | 1 | 2020 | 4 | 0.750 |
Why?
|
| Sonication | 1 | 2020 | 8 | 0.740 |
Why?
|
| Veterans | 7 | 2022 | 904 | 0.740 |
Why?
|
| Implosive Therapy | 2 | 2021 | 171 | 0.730 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2021 | 91 | 0.710 |
Why?
|
| Electromagnetic Phenomena | 4 | 2004 | 25 | 0.710 |
Why?
|
| Neuronal Plasticity | 7 | 2021 | 274 | 0.700 |
Why?
|
| Models, Neurological | 6 | 2020 | 136 | 0.690 |
Why?
|
| Electromagnetic Fields | 5 | 2018 | 66 | 0.690 |
Why?
|
| Brain Concussion | 4 | 2022 | 27 | 0.680 |
Why?
|
| Placebos | 5 | 2018 | 195 | 0.680 |
Why?
|
| Rest | 6 | 2017 | 78 | 0.660 |
Why?
|
| Sleep Deprivation | 4 | 2014 | 81 | 0.660 |
Why?
|
| Psychiatric Somatic Therapies | 1 | 2018 | 1 | 0.650 |
Why?
|
| Ultrasonic Therapy | 1 | 2018 | 19 | 0.640 |
Why?
|
| Thalamus | 6 | 2018 | 82 | 0.640 |
Why?
|
| Heart Rate | 4 | 2020 | 568 | 0.630 |
Why?
|
| Cognitive Dysfunction | 2 | 2019 | 176 | 0.620 |
Why?
|
| Evidence-Based Medicine | 4 | 2017 | 438 | 0.620 |
Why?
|
| Health Services for the Aged | 1 | 2018 | 21 | 0.610 |
Why?
|
| Gastric Bypass | 3 | 2014 | 83 | 0.610 |
Why?
|
| Autism Spectrum Disorder | 1 | 2020 | 111 | 0.610 |
Why?
|
| Calcium | 1 | 2021 | 929 | 0.600 |
Why?
|
| Ketamine | 1 | 2018 | 57 | 0.600 |
Why?
|
| Anxiety Disorders | 4 | 2008 | 426 | 0.590 |
Why?
|
| Phenanthridines | 2 | 2007 | 8 | 0.590 |
Why?
|
| Dominance, Cerebral | 6 | 2011 | 65 | 0.580 |
Why?
|
| Cognition | 3 | 2013 | 513 | 0.580 |
Why?
|
| Dopamine Agonists | 2 | 2007 | 68 | 0.570 |
Why?
|
| Substance Withdrawal Syndrome | 4 | 2013 | 435 | 0.560 |
Why?
|
| Receptors, Dopamine D1 | 2 | 2007 | 87 | 0.560 |
Why?
|
| Affect | 7 | 2015 | 218 | 0.560 |
Why?
|
| Neural Pathways | 9 | 2021 | 324 | 0.560 |
Why?
|
| Neuronavigation | 3 | 2022 | 8 | 0.550 |
Why?
|
| Cognition Disorders | 10 | 2016 | 342 | 0.530 |
Why?
|
| Pyramidal Tracts | 3 | 2019 | 45 | 0.520 |
Why?
|
| Prospective Studies | 7 | 2023 | 3705 | 0.520 |
Why?
|
| Analgesia, Patient-Controlled | 3 | 2016 | 29 | 0.520 |
Why?
|
| Speech | 3 | 2008 | 118 | 0.520 |
Why?
|
| Imagination | 4 | 2012 | 38 | 0.520 |
Why?
|
| Clinical Competence | 3 | 2020 | 657 | 0.520 |
Why?
|
| Psychotic Disorders | 1 | 2017 | 157 | 0.520 |
Why?
|
| Endometriosis | 1 | 2015 | 56 | 0.510 |
Why?
|
| Smokers | 1 | 2017 | 200 | 0.510 |
Why?
|
| Photic Stimulation | 7 | 2021 | 229 | 0.510 |
Why?
|
| Substance-Related Disorders | 2 | 2015 | 1242 | 0.510 |
Why?
|
| Neurology | 1 | 2015 | 43 | 0.490 |
Why?
|
| Reproducibility of Results | 11 | 2020 | 2077 | 0.490 |
Why?
|
| Feasibility Studies | 5 | 2021 | 652 | 0.490 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 3 | 2014 | 137 | 0.480 |
Why?
|
| Helplessness, Learned | 1 | 2014 | 9 | 0.480 |
Why?
|
| Drug Resistance | 9 | 2017 | 223 | 0.470 |
Why?
|
| Specialization | 1 | 2014 | 66 | 0.470 |
Why?
|
| Congresses as Topic | 3 | 2008 | 85 | 0.460 |
Why?
|
| Consciousness | 1 | 2013 | 17 | 0.460 |
Why?
|
| Brain Injuries, Traumatic | 3 | 2022 | 105 | 0.450 |
Why?
|
| Analysis of Variance | 10 | 2012 | 1040 | 0.450 |
Why?
|
| Thinking | 1 | 2013 | 30 | 0.450 |
Why?
|
| Neurotransmitter Agents | 1 | 2014 | 102 | 0.450 |
Why?
|
| Suicide, Attempted | 1 | 2014 | 72 | 0.450 |
Why?
|
| Suicide | 4 | 2020 | 116 | 0.450 |
Why?
|
| Education, Medical | 1 | 2015 | 147 | 0.440 |
Why?
|
| Hot Temperature | 5 | 2014 | 152 | 0.440 |
Why?
|
| Brain Waves | 3 | 2019 | 30 | 0.440 |
Why?
|
| Neurosciences | 1 | 2013 | 15 | 0.430 |
Why?
|
| Naloxone | 1 | 2013 | 56 | 0.430 |
Why?
|
| Sleep | 1 | 2015 | 263 | 0.420 |
Why?
|
| Movement Disorders | 2 | 2003 | 58 | 0.420 |
Why?
|
| Individuality | 3 | 2012 | 44 | 0.410 |
Why?
|
| Combined Modality Therapy | 7 | 2019 | 951 | 0.410 |
Why?
|
| Opioid Peptides | 1 | 2012 | 17 | 0.410 |
Why?
|
| Editorial Policies | 1 | 2012 | 32 | 0.410 |
Why?
|
| Cocaine | 1 | 2017 | 555 | 0.410 |
Why?
|
| Cerebrovascular Circulation | 9 | 2014 | 296 | 0.400 |
Why?
|
| Authorship | 5 | 2009 | 18 | 0.400 |
Why?
|
| Physical Stimulation | 3 | 2019 | 67 | 0.400 |
Why?
|
| Randomized Controlled Trials as Topic | 9 | 2021 | 931 | 0.400 |
Why?
|
| Clinical Trials as Topic | 8 | 2011 | 848 | 0.400 |
Why?
|
| Sensation | 3 | 2009 | 49 | 0.390 |
Why?
|
| Diagnostic Imaging | 3 | 2015 | 201 | 0.390 |
Why?
|
| Neuropsychological Tests | 12 | 2018 | 517 | 0.390 |
Why?
|
| Thermosensing | 1 | 2011 | 10 | 0.390 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2013 | 146 | 0.390 |
Why?
|
| Physicians | 1 | 2015 | 324 | 0.390 |
Why?
|
| Fibromyalgia | 1 | 2011 | 29 | 0.380 |
Why?
|
| Surveys and Questionnaires | 7 | 2020 | 2800 | 0.380 |
Why?
|
| Hydromorphone | 1 | 2011 | 14 | 0.380 |
Why?
|
| Somatosensory Cortex | 1 | 2011 | 22 | 0.380 |
Why?
|
| Image Enhancement | 2 | 2016 | 143 | 0.380 |
Why?
|
| Food Preferences | 1 | 2011 | 46 | 0.380 |
Why?
|
| Publishing | 1 | 2012 | 89 | 0.380 |
Why?
|
| Sensory Thresholds | 2 | 2011 | 50 | 0.370 |
Why?
|
| Electrodes | 5 | 2022 | 147 | 0.370 |
Why?
|
| Food | 1 | 2011 | 52 | 0.370 |
Why?
|
| Biofeedback, Psychology | 1 | 2010 | 23 | 0.370 |
Why?
|
| Computer Simulation | 4 | 2018 | 706 | 0.370 |
Why?
|
| Brain Injuries | 3 | 2022 | 268 | 0.360 |
Why?
|
| Abdominal Pain | 1 | 2011 | 97 | 0.360 |
Why?
|
| Bed Rest | 1 | 2010 | 17 | 0.350 |
Why?
|
| Tomography, Emission-Computed | 4 | 2003 | 40 | 0.350 |
Why?
|
| Curriculum | 1 | 2014 | 575 | 0.350 |
Why?
|
| Hippocampus | 3 | 2021 | 471 | 0.340 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2009 | 37 | 0.340 |
Why?
|
| Conditioning, Classical | 1 | 2009 | 57 | 0.330 |
Why?
|
| Magnetic Field Therapy | 1 | 2008 | 1 | 0.330 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2021 | 266 | 0.330 |
Why?
|
| Head | 2 | 2009 | 59 | 0.330 |
Why?
|
| Feeding Behavior | 1 | 2011 | 224 | 0.330 |
Why?
|
| Consensus | 7 | 2022 | 211 | 0.330 |
Why?
|
| Motor Activity | 4 | 2020 | 621 | 0.330 |
Why?
|
| Models, Anatomic | 1 | 2009 | 51 | 0.320 |
Why?
|
| Central Nervous System Agents | 1 | 2009 | 37 | 0.320 |
Why?
|
| Galvanic Skin Response | 1 | 2009 | 67 | 0.320 |
Why?
|
| Crime | 1 | 2008 | 53 | 0.320 |
Why?
|
| Leg | 1 | 2010 | 191 | 0.320 |
Why?
|
| Adaptation, Physiological | 1 | 2010 | 189 | 0.320 |
Why?
|
| Alcoholism | 3 | 2018 | 1109 | 0.320 |
Why?
|
| Algorithms | 4 | 2016 | 1196 | 0.310 |
Why?
|
| Linear Models | 5 | 2012 | 521 | 0.310 |
Why?
|
| Internship and Residency | 1 | 2014 | 596 | 0.310 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2007 | 84 | 0.300 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2011 | 348 | 0.300 |
Why?
|
| Bioethics | 1 | 2007 | 7 | 0.300 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2019 | 124 | 0.300 |
Why?
|
| Stroke Rehabilitation | 5 | 2020 | 335 | 0.300 |
Why?
|
| Treatment Failure | 1 | 2008 | 216 | 0.300 |
Why?
|
| Follow-Up Studies | 8 | 2020 | 3259 | 0.290 |
Why?
|
| White Matter | 2 | 2022 | 174 | 0.290 |
Why?
|
| Antipsychotic Agents | 2 | 2007 | 247 | 0.290 |
Why?
|
| Fatigue | 2 | 2005 | 132 | 0.290 |
Why?
|
| Animals | 15 | 2017 | 20881 | 0.280 |
Why?
|
| Appetite Regulation | 1 | 2006 | 11 | 0.280 |
Why?
|
| Reference Values | 6 | 2011 | 579 | 0.280 |
Why?
|
| Motivation | 4 | 2013 | 561 | 0.280 |
Why?
|
| Efferent Pathways | 1 | 2006 | 15 | 0.280 |
Why?
|
| Calcium Channel Blockers | 2 | 2004 | 138 | 0.280 |
Why?
|
| Aphasia | 2 | 2018 | 119 | 0.280 |
Why?
|
| Case-Control Studies | 8 | 2015 | 1553 | 0.270 |
Why?
|
| Eating | 1 | 2006 | 119 | 0.270 |
Why?
|
| Executive Function | 2 | 2019 | 106 | 0.270 |
Why?
|
| Stroke | 6 | 2018 | 2163 | 0.270 |
Why?
|
| Military Personnel | 3 | 2022 | 221 | 0.260 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2018 | 239 | 0.260 |
Why?
|
| Cluster Analysis | 4 | 2020 | 219 | 0.260 |
Why?
|
| Lower Extremity | 1 | 2007 | 153 | 0.260 |
Why?
|
| Verbal Learning | 1 | 2005 | 29 | 0.250 |
Why?
|
| Social Behavior | 2 | 2004 | 164 | 0.250 |
Why?
|
| Physical Therapy Modalities | 2 | 2003 | 133 | 0.250 |
Why?
|
| Skull | 4 | 2009 | 63 | 0.250 |
Why?
|
| Electricity | 2 | 2022 | 33 | 0.250 |
Why?
|
| Recurrence | 4 | 2015 | 948 | 0.250 |
Why?
|
| Health Status | 3 | 2018 | 429 | 0.250 |
Why?
|
| Courtship | 1 | 2004 | 13 | 0.250 |
Why?
|
| Urea | 1 | 2004 | 51 | 0.240 |
Why?
|
| Skin | 1 | 2008 | 451 | 0.240 |
Why?
|
| Grief | 1 | 2004 | 32 | 0.240 |
Why?
|
| Narcotic Antagonists | 2 | 2018 | 184 | 0.240 |
Why?
|
| Tourette Syndrome | 1 | 2004 | 8 | 0.240 |
Why?
|
| Electromyography | 5 | 2020 | 184 | 0.230 |
Why?
|
| Biomedical Research | 1 | 2007 | 310 | 0.230 |
Why?
|
| Quality of Life | 4 | 2021 | 1515 | 0.230 |
Why?
|
| Severity of Illness Index | 5 | 2011 | 1851 | 0.230 |
Why?
|
| Homeostasis | 2 | 2015 | 291 | 0.230 |
Why?
|
| Chronic Disease | 5 | 2009 | 1330 | 0.230 |
Why?
|
| Phobic Disorders | 1 | 2004 | 227 | 0.220 |
Why?
|
| Psychosurgery | 1 | 2023 | 9 | 0.220 |
Why?
|
| Interpersonal Relations | 1 | 2004 | 209 | 0.220 |
Why?
|
| Perception | 4 | 2019 | 189 | 0.220 |
Why?
|
| Inservice Training | 1 | 2003 | 68 | 0.210 |
Why?
|
| Exercise | 2 | 2019 | 658 | 0.210 |
Why?
|
| Auditory Cortex | 1 | 2003 | 43 | 0.210 |
Why?
|
| Neurosurgery | 1 | 2023 | 42 | 0.210 |
Why?
|
| Thalamic Nuclei | 1 | 2002 | 9 | 0.210 |
Why?
|
| Maternal Behavior | 1 | 2002 | 29 | 0.200 |
Why?
|
| Reaction Time | 5 | 2005 | 170 | 0.200 |
Why?
|
| Sensitivity and Specificity | 4 | 2016 | 1753 | 0.200 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2016 | 237 | 0.200 |
Why?
|
| Acute Disease | 3 | 2012 | 658 | 0.200 |
Why?
|
| Anxiety | 1 | 2004 | 422 | 0.190 |
Why?
|
| Healthy Volunteers | 2 | 2020 | 78 | 0.190 |
Why?
|
| Brain Chemistry | 2 | 2014 | 173 | 0.190 |
Why?
|
| Mood Disorders | 3 | 2005 | 132 | 0.190 |
Why?
|
| Task Performance and Analysis | 4 | 2014 | 150 | 0.190 |
Why?
|
| Smoking Prevention | 2 | 2013 | 259 | 0.190 |
Why?
|
| United States Food and Drug Administration | 1 | 2021 | 131 | 0.190 |
Why?
|
| Regional Blood Flow | 3 | 2007 | 168 | 0.190 |
Why?
|
| Taste | 1 | 2001 | 49 | 0.190 |
Why?
|
| Aged, 80 and over | 6 | 2017 | 4848 | 0.190 |
Why?
|
| Attention | 3 | 1998 | 225 | 0.180 |
Why?
|
| Secondary Prevention | 4 | 2012 | 291 | 0.180 |
Why?
|
| Visual Perception | 3 | 2008 | 124 | 0.180 |
Why?
|
| Cortical Excitability | 1 | 2020 | 7 | 0.180 |
Why?
|
| Statistics as Topic | 2 | 2015 | 219 | 0.180 |
Why?
|
| Alcohol Drinking | 2 | 2004 | 805 | 0.180 |
Why?
|
| Patient-Specific Modeling | 1 | 2020 | 18 | 0.180 |
Why?
|
| United States | 4 | 2021 | 7367 | 0.180 |
Why?
|
| Torticollis | 2 | 2012 | 15 | 0.180 |
Why?
|
| Neurological Rehabilitation | 1 | 2020 | 12 | 0.180 |
Why?
|
| Feeding and Eating Disorders | 1 | 2022 | 106 | 0.180 |
Why?
|
| Health Personnel | 1 | 2003 | 286 | 0.180 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2019 | 20 | 0.170 |
Why?
|
| Hand | 3 | 2012 | 90 | 0.170 |
Why?
|
| Temporal Lobe | 4 | 2018 | 125 | 0.170 |
Why?
|
| Synapses | 1 | 2021 | 222 | 0.170 |
Why?
|
| Obesity | 1 | 2006 | 1076 | 0.170 |
Why?
|
| Cortical Synchronization | 1 | 2019 | 6 | 0.160 |
Why?
|
| Volition | 2 | 2012 | 16 | 0.160 |
Why?
|
| Psychomotor Performance | 4 | 2018 | 213 | 0.160 |
Why?
|
| Post-Concussion Syndrome | 1 | 2018 | 4 | 0.160 |
Why?
|
| Speech Therapy | 1 | 2018 | 19 | 0.160 |
Why?
|
| Ankle | 1 | 2019 | 45 | 0.160 |
Why?
|
| Touch Perception | 1 | 2019 | 18 | 0.160 |
Why?
|
| Lidocaine | 2 | 2010 | 36 | 0.160 |
Why?
|
| Laboratories | 1 | 2019 | 44 | 0.160 |
Why?
|
| History, 21st Century | 2 | 2013 | 127 | 0.160 |
Why?
|
| Electrodes, Implanted | 2 | 2017 | 98 | 0.150 |
Why?
|
| Gait Disorders, Neurologic | 2 | 2017 | 86 | 0.150 |
Why?
|
| Receptors, Opioid | 1 | 2018 | 60 | 0.150 |
Why?
|
| Discrimination Learning | 1 | 1998 | 45 | 0.150 |
Why?
|
| Facial Expression | 1 | 1998 | 36 | 0.150 |
Why?
|
| Caudate Nucleus | 1 | 2018 | 56 | 0.150 |
Why?
|
| History, 20th Century | 2 | 2013 | 248 | 0.150 |
Why?
|
| Upper Extremity | 2 | 2017 | 112 | 0.150 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 3 | 2013 | 257 | 0.150 |
Why?
|
| Pandemics | 1 | 2021 | 352 | 0.150 |
Why?
|
| Hydrocortisone | 1 | 2019 | 291 | 0.150 |
Why?
|
| Recovery of Function | 2 | 2018 | 506 | 0.150 |
Why?
|
| Pediatrics | 1 | 2021 | 341 | 0.150 |
Why?
|
| Exercise Therapy | 1 | 2019 | 183 | 0.150 |
Why?
|
| Models, Biological | 3 | 2011 | 981 | 0.140 |
Why?
|
| Demography | 3 | 2008 | 279 | 0.140 |
Why?
|
| Chi-Square Distribution | 2 | 2010 | 546 | 0.140 |
Why?
|
| Muscle, Skeletal | 2 | 2019 | 396 | 0.140 |
Why?
|
| Injections, Subcutaneous | 2 | 2007 | 87 | 0.140 |
Why?
|
| Morphine | 2 | 2008 | 76 | 0.140 |
Why?
|
| Connectome | 1 | 2018 | 92 | 0.140 |
Why?
|
| Health Surveys | 1 | 2018 | 489 | 0.140 |
Why?
|
| Psychotherapy | 1 | 2019 | 253 | 0.140 |
Why?
|
| Dura Mater | 1 | 2016 | 23 | 0.140 |
Why?
|
| Neuropsychology | 2 | 2007 | 11 | 0.140 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2018 | 211 | 0.140 |
Why?
|
| Subtraction Technique | 1 | 2016 | 12 | 0.140 |
Why?
|
| Positron-Emission Tomography | 4 | 2014 | 160 | 0.140 |
Why?
|
| Genotype | 1 | 2018 | 786 | 0.130 |
Why?
|
| Amygdala | 2 | 2014 | 159 | 0.130 |
Why?
|
| Retreatment | 1 | 2015 | 59 | 0.130 |
Why?
|
| Galantamine | 1 | 2015 | 9 | 0.130 |
Why?
|
| Watchful Waiting | 1 | 2015 | 25 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 772 | 0.130 |
Why?
|
| Inpatients | 2 | 2014 | 208 | 0.130 |
Why?
|
| Models, Statistical | 2 | 2010 | 448 | 0.130 |
Why?
|
| Art | 1 | 2015 | 2 | 0.130 |
Why?
|
| South Carolina | 2 | 2013 | 2752 | 0.130 |
Why?
|
| Emotional Intelligence | 1 | 2015 | 5 | 0.130 |
Why?
|
| Lumbar Vertebrae | 1 | 2016 | 112 | 0.130 |
Why?
|
| Peripheral Nerves | 1 | 2015 | 22 | 0.120 |
Why?
|
| Association Learning | 1 | 2015 | 36 | 0.120 |
Why?
|
| Research Report | 1 | 2015 | 35 | 0.120 |
Why?
|
| Psychophysics | 1 | 2014 | 30 | 0.120 |
Why?
|
| Phototherapy | 1 | 2014 | 28 | 0.120 |
Why?
|
| Methylphenidate | 1 | 2015 | 97 | 0.120 |
Why?
|
| Hospitals, Military | 1 | 2014 | 13 | 0.120 |
Why?
|
| Neurons | 2 | 2014 | 881 | 0.120 |
Why?
|
| Telemedicine | 1 | 2022 | 700 | 0.120 |
Why?
|
| Gray Matter | 1 | 2014 | 57 | 0.120 |
Why?
|
| Biomarkers | 4 | 2021 | 1593 | 0.120 |
Why?
|
| Marijuana Abuse | 1 | 2017 | 251 | 0.120 |
Why?
|
| Neuroimaging | 1 | 2015 | 122 | 0.120 |
Why?
|
| Arousal | 4 | 2013 | 168 | 0.110 |
Why?
|
| Reward | 1 | 2015 | 201 | 0.110 |
Why?
|
| Anisotropy | 2 | 2011 | 105 | 0.110 |
Why?
|
| Spinal Cord | 1 | 2015 | 244 | 0.110 |
Why?
|
| Nicotine | 1 | 2017 | 350 | 0.110 |
Why?
|
| Hospitals, Veterans | 1 | 2014 | 147 | 0.110 |
Why?
|
| Societies, Medical | 1 | 2016 | 403 | 0.110 |
Why?
|
| Databases, Factual | 2 | 2019 | 622 | 0.110 |
Why?
|
| Hearing | 1 | 2014 | 133 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 1745 | 0.110 |
Why?
|
| France | 1 | 2013 | 26 | 0.110 |
Why?
|
| Data Interpretation, Statistical | 3 | 2012 | 329 | 0.110 |
Why?
|
| Orientation | 1 | 2013 | 31 | 0.110 |
Why?
|
| Speech Perception | 1 | 1996 | 261 | 0.110 |
Why?
|
| Alcoholic Beverages | 2 | 2004 | 18 | 0.110 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2013 | 92 | 0.110 |
Why?
|
| Quinoxalines | 1 | 2013 | 78 | 0.110 |
Why?
|
| Multivariate Analysis | 2 | 2022 | 1046 | 0.100 |
Why?
|
| Benzazepines | 1 | 2013 | 104 | 0.100 |
Why?
|
| Cohort Studies | 3 | 2021 | 2358 | 0.100 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 2550 | 0.100 |
Why?
|
| Temperature | 1 | 2013 | 341 | 0.100 |
Why?
|
| Methamphetamine | 1 | 2013 | 132 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2013 | 172 | 0.100 |
Why?
|
| Cold Temperature | 1 | 2011 | 90 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 1 | 2013 | 221 | 0.100 |
Why?
|
| Weight Loss | 1 | 2013 | 319 | 0.090 |
Why?
|
| Medical Records | 1 | 2011 | 121 | 0.090 |
Why?
|
| Contraindications | 2 | 2018 | 52 | 0.090 |
Why?
|
| Computer Systems | 1 | 2010 | 42 | 0.090 |
Why?
|
| Software | 2 | 2022 | 418 | 0.090 |
Why?
|
| Research Design | 2 | 2018 | 729 | 0.090 |
Why?
|
| Prilocaine | 1 | 2010 | 2 | 0.090 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 1465 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 2279 | 0.090 |
Why?
|
| Suicidal Ideation | 2 | 2021 | 106 | 0.090 |
Why?
|
| Facial Neuralgia | 1 | 2009 | 4 | 0.090 |
Why?
|
| Webcasts as Topic | 1 | 2009 | 3 | 0.090 |
Why?
|
| Veterans Health | 2 | 2021 | 62 | 0.090 |
Why?
|
| Affective Symptoms | 2 | 2015 | 50 | 0.080 |
Why?
|
| Mandibular Diseases | 1 | 2009 | 28 | 0.080 |
Why?
|
| Brain Ischemia | 1 | 2015 | 665 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 1 | 2010 | 186 | 0.080 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2014 | 81 | 0.080 |
Why?
|
| Optics and Photonics | 1 | 2009 | 29 | 0.080 |
Why?
|
| Forensic Medicine | 1 | 2008 | 26 | 0.080 |
Why?
|
| Videotape Recording | 1 | 2008 | 43 | 0.080 |
Why?
|
| Device Approval | 1 | 2008 | 6 | 0.080 |
Why?
|
| Basal Ganglia | 2 | 2007 | 45 | 0.080 |
Why?
|
| Action Potentials | 1 | 2010 | 223 | 0.080 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2008 | 6 | 0.080 |
Why?
|
| Hospitalization | 1 | 2014 | 978 | 0.080 |
Why?
|
| Computational Biology | 1 | 2009 | 190 | 0.080 |
Why?
|
| PubMed | 1 | 2007 | 21 | 0.080 |
Why?
|
| Evoked Potentials | 1 | 2008 | 61 | 0.080 |
Why?
|
| Atrophy | 2 | 2007 | 112 | 0.080 |
Why?
|
| Remission Induction | 1 | 2008 | 111 | 0.080 |
Why?
|
| Schizophrenic Psychology | 1 | 2007 | 53 | 0.080 |
Why?
|
| Drug Therapy, Combination | 2 | 2007 | 649 | 0.080 |
Why?
|
| Canada | 1 | 2008 | 267 | 0.080 |
Why?
|
| ROC Curve | 1 | 2008 | 392 | 0.070 |
Why?
|
| Australia | 1 | 2008 | 235 | 0.070 |
Why?
|
| Panic Disorder | 1 | 2008 | 121 | 0.070 |
Why?
|
| Recruitment, Neurophysiological | 1 | 2007 | 6 | 0.070 |
Why?
|
| Afferent Pathways | 1 | 2007 | 31 | 0.070 |
Why?
|
| Casts, Surgical | 1 | 2007 | 13 | 0.070 |
Why?
|
| Immobilization | 1 | 2007 | 26 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 567 | 0.070 |
Why?
|
| Administration, Topical | 1 | 2006 | 111 | 0.070 |
Why?
|
| Epinephrine | 1 | 2006 | 103 | 0.070 |
Why?
|
| Neurobiology | 1 | 2006 | 9 | 0.070 |
Why?
|
| Monte Carlo Method | 1 | 2006 | 124 | 0.070 |
Why?
|
| Anesthetics, Local | 1 | 2006 | 83 | 0.070 |
Why?
|
| Speech Disorders | 1 | 2005 | 7 | 0.070 |
Why?
|
| Cholestyramine Resin | 1 | 2005 | 3 | 0.070 |
Why?
|
| Verbal Behavior | 1 | 2005 | 27 | 0.070 |
Why?
|
| Safety | 1 | 2006 | 145 | 0.060 |
Why?
|
| Calibration | 1 | 2005 | 73 | 0.060 |
Why?
|
| Vocabulary | 1 | 2005 | 14 | 0.060 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2005 | 8 | 0.060 |
Why?
|
| Love | 1 | 2004 | 3 | 0.060 |
Why?
|
| Peroxides | 1 | 2004 | 23 | 0.060 |
Why?
|
| Psychotropic Drugs | 1 | 2005 | 83 | 0.060 |
Why?
|
| Hallucinations | 1 | 2004 | 19 | 0.060 |
Why?
|
| Probability | 1 | 2005 | 245 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2020 | 2455 | 0.060 |
Why?
|
| Wakefulness | 1 | 2005 | 75 | 0.060 |
Why?
|
| Logistic Models | 1 | 2009 | 1420 | 0.060 |
Why?
|
| Differential Threshold | 1 | 2004 | 27 | 0.060 |
Why?
|
| Wrist | 2 | 2019 | 24 | 0.060 |
Why?
|
| Likelihood Functions | 1 | 2004 | 106 | 0.060 |
Why?
|
| Pregnancy | 1 | 2010 | 2334 | 0.060 |
Why?
|
| Truth Disclosure | 1 | 2004 | 48 | 0.060 |
Why?
|
| Drug Combinations | 1 | 2004 | 304 | 0.060 |
Why?
|
| Contrast Media | 1 | 2007 | 595 | 0.060 |
Why?
|
| Long-Term Care | 1 | 2004 | 53 | 0.060 |
Why?
|
| Beverages | 1 | 2004 | 50 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2021 | 7277 | 0.060 |
Why?
|
| Indans | 1 | 2003 | 20 | 0.060 |
Why?
|
| Electrophysiology | 1 | 2003 | 160 | 0.060 |
Why?
|
| Radiopharmaceuticals | 1 | 2003 | 114 | 0.060 |
Why?
|
| Nimodipine | 1 | 2003 | 5 | 0.050 |
Why?
|
| Diffusion | 1 | 2003 | 90 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2005 | 340 | 0.050 |
Why?
|
| Thumb | 1 | 2003 | 27 | 0.050 |
Why?
|
| Somatostatin | 1 | 2003 | 36 | 0.050 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2003 | 58 | 0.050 |
Why?
|
| Piperidines | 1 | 2003 | 123 | 0.050 |
Why?
|
| Blood-Brain Barrier | 1 | 2003 | 99 | 0.050 |
Why?
|
| Motor Skills | 1 | 2003 | 88 | 0.050 |
Why?
|
| Alpha Rhythm | 1 | 2022 | 3 | 0.050 |
Why?
|
| Preoptic Area | 1 | 2002 | 19 | 0.050 |
Why?
|
| Water | 1 | 2003 | 230 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2005 | 705 | 0.050 |
Why?
|
| Neurosurgical Procedures | 1 | 2023 | 98 | 0.050 |
Why?
|
| Sex Factors | 1 | 2004 | 1266 | 0.050 |
Why?
|
| Stereotaxic Techniques | 1 | 2020 | 35 | 0.050 |
Why?
|
| Decision Making | 1 | 2004 | 410 | 0.050 |
Why?
|
| Personality Inventory | 1 | 2001 | 197 | 0.050 |
Why?
|
| Datasets as Topic | 1 | 2020 | 53 | 0.040 |
Why?
|
| Haplorhini | 1 | 1999 | 44 | 0.040 |
Why?
|
| Physical Exertion | 1 | 2019 | 75 | 0.040 |
Why?
|
| Aphasia, Broca | 1 | 2018 | 11 | 0.040 |
Why?
|
| Language Therapy | 1 | 2018 | 9 | 0.040 |
Why?
|
| Vibration | 1 | 2019 | 32 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2018 | 38 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2002 | 631 | 0.040 |
Why?
|
| Risk Factors | 2 | 2006 | 5731 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2004 | 824 | 0.040 |
Why?
|
| Pattern Recognition, Visual | 1 | 1998 | 69 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2019 | 230 | 0.040 |
Why?
|
| Color Perception Tests | 1 | 1997 | 1 | 0.040 |
Why?
|
| Postural Balance | 1 | 2017 | 93 | 0.040 |
Why?
|
| Self Report | 1 | 2018 | 371 | 0.030 |
Why?
|
| Epidural Space | 1 | 2016 | 15 | 0.030 |
Why?
|
| Random Allocation | 1 | 1997 | 442 | 0.030 |
Why?
|
| Subthalamic Nucleus | 1 | 2015 | 16 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2017 | 99 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 1619 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 121 | 0.030 |
Why?
|
| Aging | 1 | 2002 | 911 | 0.030 |
Why?
|
| Apathy | 1 | 2015 | 28 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2016 | 49 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 627 | 0.030 |
Why?
|
| Infant | 1 | 2002 | 2891 | 0.030 |
Why?
|
| Anesthesia | 1 | 2016 | 120 | 0.030 |
Why?
|
| Walking | 1 | 2017 | 241 | 0.030 |
Why?
|
| Aftercare | 1 | 2016 | 114 | 0.030 |
Why?
|
| Parahippocampal Gyrus | 1 | 2014 | 15 | 0.030 |
Why?
|
| Advisory Committees | 1 | 2015 | 73 | 0.030 |
Why?
|
| Equipment Design | 1 | 2016 | 500 | 0.030 |
Why?
|
| Globus Pallidus | 1 | 2014 | 64 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 242 | 0.030 |
Why?
|
| Comorbidity | 1 | 2018 | 1426 | 0.030 |
Why?
|
| Perfusion | 1 | 2014 | 131 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 2014 | 206 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2013 | 238 | 0.030 |
Why?
|
| Varenicline | 1 | 2013 | 98 | 0.030 |
Why?
|
| Nicotinic Agonists | 1 | 2013 | 111 | 0.030 |
Why?
|
| Body Temperature | 1 | 2012 | 116 | 0.020 |
Why?
|
| Epilepsy | 1 | 1996 | 336 | 0.020 |
Why?
|
| Learning | 1 | 2013 | 186 | 0.020 |
Why?
|
| Forehead | 1 | 2010 | 13 | 0.020 |
Why?
|
| Child | 1 | 2021 | 6405 | 0.020 |
Why?
|
| Kinesthesis | 1 | 2009 | 3 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1864 | 0.020 |
Why?
|
| Proprioception | 1 | 2009 | 10 | 0.020 |
Why?
|
| Magnetoencephalography | 1 | 2009 | 6 | 0.020 |
Why?
|
| Arm | 1 | 2009 | 59 | 0.020 |
Why?
|
| Rats | 1 | 2017 | 5300 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2009 | 131 | 0.020 |
Why?
|
| Prognosis | 1 | 2013 | 2093 | 0.020 |
Why?
|
| Cell Count | 1 | 2008 | 248 | 0.020 |
Why?
|
| Patient Selection | 1 | 2012 | 592 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2010 | 333 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2009 | 159 | 0.020 |
Why?
|
| Fingers | 1 | 2007 | 39 | 0.020 |
Why?
|
| Audiometry | 1 | 2007 | 50 | 0.020 |
Why?
|
| Glucose | 1 | 2008 | 307 | 0.020 |
Why?
|
| Neurons, Afferent | 1 | 2006 | 32 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2006 | 219 | 0.020 |
Why?
|
| Thoracic Wall | 1 | 2006 | 20 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2007 | 737 | 0.020 |
Why?
|
| Amnesia | 1 | 2004 | 17 | 0.020 |
Why?
|
| Dizziness | 1 | 2004 | 27 | 0.020 |
Why?
|
| Headache | 1 | 2004 | 68 | 0.010 |
Why?
|
| Periodicity | 1 | 2004 | 43 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 2003 | 87 | 0.010 |
Why?
|
| Outpatients | 1 | 2003 | 127 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2004 | 504 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2002 | 222 | 0.010 |
Why?
|